?

Norton Johna

EVP, Global Quality
Eli Lilly and Company
US, Indianapolis [HQ]
CIK 1702471

Data Source

We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.

Latest Information

Shares :
25,428
Price per Share :
$725.72
Equivalence :
$18,453,608.16

Transaction History

  • S
    Form 4
    25,428 Shares After Transaction
    Value : $20,835,194.64
    Sold $5,781,545.28
    06/03/24
  • Footnotes:
    #1 The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2024.
    #2 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $818.80 to $819.59, inclusive. The reporting person undertakes to provide to Eli Lilly and Company, any security holder of Eli Lilly and Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  • M
    Form 4
    31,382 Shares After Transaction
    Value : $n/a
    $0.0
    02/01/24
  • F
    Form 4
    30,816 Shares After Transaction
    Value : $19,895,117.76
    $365,415.26
    02/01/24
  • A
    Form 4
    32,484 Shares After Transaction
    Value : $23,949,153.84
    $1,229,749.68
    02/12/24